PTO/SB/96 (07-09)
`Approved for use through 07/31/2012. OMB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Retluctfon Act of 1995, no persons are requiretl to respontl to a conecUon of inrormation unless it aispiays a
`
`STATEMENT UNDER 37 CFR 3.73(b)
`
`ApplicanUPatent Owner:
`
`AstraZeneca AB
`
`Application No./Patent No.:
`7,759,328
`Titled:
`COMPOSITION FOR INHALATION
`
`Filed/Issue Date:
`
`July 20, 2010
`
`AstraZeneca AB
`(Name of Assignee)
`
`corporation
`, a
`(Type of Assignee, e.g., corporation, partnership, university, government agency, etc.
`
`states that it is:
`1. ~x the assignee of the entire right, title, and interest in;
`
`2~ ~ an assignee of less than the entire right, title, and interest in
`(The extent (by percentage) of its ownership interest is
`
`°/o); or
`
`3. ~ the assignee of an undivided interest in the entirety of (a complete assignment from one of the joint inventors was made)
`the patent application/patent identified above, by virtue of either:
`
`A. ~ An assignment from the inventors) of the patent application/patent identified above. The assignment was
`,
`recorded in the United States Patent and Trademark Office at Reel
`or for which a copy therefore is attached.
`Frame
`
`OR
`g. ~ A chain of title from the inventor(s), of the patent application/patent identified above, to the current assignee as follows:
`
`To: AstraZeneca AB
`From: Inventors Govind and Marlow
`The document was recorded in the United States Patent and Trademark Office at
`, or for which a copy thereof is attached.
`Reel
`015506
`,Frame
`0145
`
`To:
`2. From:
`The document was recorded in the United States Patent and Trademark Office at
`, or for which a copy thereof is attached.
`Reel
`,Frame
`
`To:
`3. From:
`The document was recorded in the United States Patent and Trademark Office at
`, or for which a copy thereof is attached.
`Reel
`,Frame
`
`Additional documents in the chain of title are listed on a supplemental sheet(s).
`
`As required by 37 CFR 3.73(b)(1)(i), the documentary evidence of the chain of title from the original owner to the assignee
`was, or concurrently is being, submitted for recordation pursuant to 37 CFR 3.11.
`[NOTE: A separate copy (i.e., a true copy of the original assignment document(s)) must be submitted to Assignment Division
`in accordance with 37 CFR Part 3, to record the assignment in the records of the USPTO. See MPEP 302.081
`The undersigned (whose ~ e is supplied below) is authorized to act on behalf of the assignee. /
`~Ud~.~-cvW~ i~0/ 7
`Date
`
`ignatur
`
`1~~h/7 (fib i N J~1 ~f~ N~G~
`Printed or Typed Name
`
`~Fi~ui ~ Gl ~c~- L4~J~,5
`Title
`
`DC: 6343602-1
`
`

`

`IN THE U1vITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`COMPLEX INNOVATIONS, LLC,
`Petitioner,
`
`v.
`
`ASTRAZENECA AB,
`Patent Owner.
`
`Case No. IPR2017-00631
`Patent No. 7,759,328
`
`POWER OF ATTORNEY FROM PATENT OWNER
`ASTRAZENECA AB
`
`DC: 6343606-1
`
`

`

`IPR2017-00631
`
`Pursuant to 37 C.F.R. § 42.10(b), Patent Owner AstraZeneca AB hereby
`
`appoints the practitioners associated with Customer Number 26853, including the
`
`following lead and back-up counsel, as its attorneys to transact all business in the
`
`United States Patent &Trademark Office associated with the above-captioned
`
`Inter' Partes Review.
`
`A Statement Under 37 C.F.R. § 3.73 (b) is submitted herewith.
`
`Back-U Counsel
`Lead Counsel
`Andrea G. Reister (Reg. No. 36,253)
`Christopher Sipes (Reg. No. 39,837)
`areister@cov.com
`csipes@cov.com
`Postal and Hand-Delivery Address:
`Postal and Hand-Delivery Address:
`Covington &Burling LLP
`Covington &Burling LLP
`One CityCenter, 850 Tenth Street, NW One CityCenter, 850 Tenth Street, NW
`Washington, DC 20001
`Washington, DC 20001
`Phone: (202) 662-5141
`Phone: (202) 662-5525
`Fax: (202) 778-5141
`Fax: (202) 778-5525
`
`The individual signing below has the authority to execute this document on
`
`behalf of Patent Owner AstraZeneca AB.
`
`Date: ~~ ~{~ ~,t,c~w, ~ol~
`
`Name:
`
`Title:
`
`d~~%',~ (r~~`~~ L c~clN:~2
`
`

`

`CERTinCATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6,1 hereby certify that on this 12th day of April 2017, the
`
`foregoing Power of Attorney from Patent Owner AstraZeneca AB, and
`
`accompanying Statement Under 37 C.F.R. § 3.73(b), was served by electronic mail
`
`and FedEx, a means at least as fast and reliable as Priority Mail Express®, on the
`
`following counsel of record for petitioner.
`
`Sharad K. Bijanki (sb@hkw-law.com)
`Vivek Ganti (vg@hkw-law.com)
`Hill, Kertscher & Wharton, LLP
`3350 Riverwood Parkway SE, Suite 800
`Atlanta, OA 30339
`
`Date: April 12, 2017
`
`/s/Andrea G. Reister
`Andrea G. Reister, Esq.
`Registration No.: 36,253
`
`